Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2026-06-15 18:46:33 ET · period of report 2026-06-15 · accession 0001677455-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-15 18:46 | 2026-06-15 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $24.62 | -1,899 | 94.5K | -2% | -$46.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-15 | S | D | 1,899 | $24.62 | 94,462 | D | — | — | (F1) Includes 646 shares acquired under the Company's Amended and Restated Employee Stock Purchase Place on April 30, 2026 (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |